These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 15067768)

  • 1. [Clinical biochemistry: heart hormones. The Danish Society of Biochemistry].
    Gøtze JP; Rehfeld JF
    Ugeskr Laeger; 2004 Mar; 166(12):1109. PubMed ID: 15067768
    [No Abstract]   [Full Text] [Related]  

  • 2. Natriuretic peptides and remodeling in heart failure.
    Burnett JC
    Heart Fail Clin; 2005 Apr; 1(1):129-39. PubMed ID: 17386839
    [No Abstract]   [Full Text] [Related]  

  • 3. The role and assessment of ventricular peptides in heart failure.
    Winter WE; Elin RJ
    Clin Lab Med; 2004 Mar; 24(1):235-74. PubMed ID: 15157565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Natriuretic peptides and their use in clinical practice according to the guidelines of the European Society of Cardiology].
    Stryjewski PJ; Nessler B; Paweł M; Badacz L; Nowak J; Nessler J
    Przegl Lek; 2014; 71(1):33-5. PubMed ID: 24712266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular and metabolic effects of natriuretic peptides.
    Moro C; Berlan M
    Fundam Clin Pharmacol; 2006 Feb; 20(1):41-9. PubMed ID: 16448393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natriuretic peptides and the heart: current and future implications for clinical biochemistry.
    Penney MD
    Ann Clin Biochem; 2005 Nov; 42(Pt 6):432-40. PubMed ID: 16259793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic problem - heart failure with preserved ejection fraction].
    Kilian N; Wlazłowski R
    Kardiol Pol; 2012; 70(3):282-6. PubMed ID: 22430414
    [No Abstract]   [Full Text] [Related]  

  • 8. Natriuretic peptides and heart failure in the patient with chronic kidney disease: a review of current evidence.
    Dhar S; Pressman GS; Subramanian S; Kaul S; Gollamudi S; Bloom EJ; Figueredo VM
    Postgrad Med J; 2009 Jun; 85(1004):299-302. PubMed ID: 19528304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical utilization of cardiac biomarker testing in heart failure.
    Tang WH; Francis GS; Morrow DA; Newby LK; Cannon CP; Jesse RL; Storrow AB; Christenson RH;
    Clin Biochem; 2008 Mar; 41(4-5):210-21. PubMed ID: 18048022
    [No Abstract]   [Full Text] [Related]  

  • 10. Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases.
    Rubattu S; Sciarretta S; Valenti V; Stanzione R; Volpe M
    Am J Hypertens; 2008 Jul; 21(7):733-41. PubMed ID: 18464748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Accreditation of clinical biochemical departments. The Danish Society of Clinical Biochemistry].
    Gerdes U; Hilsted LM; Jørgensen HL;
    Ugeskr Laeger; 2007 Mar; 169(12):1112. PubMed ID: 17394823
    [No Abstract]   [Full Text] [Related]  

  • 12. [Discovery and significance of natriuretic peptides].
    Nakao K; Tamura N
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():5-9. PubMed ID: 15506327
    [No Abstract]   [Full Text] [Related]  

  • 13. [Uniform reference intervals and harmonised results in clinical biochemistry in Scandinavia--light ahead].
    Brandslund I; Poulsen JH; Petersen PH; Pedersen ML; Gerdes LU; Plum I
    Ugeskr Laeger; 2007 Mar; 169(13):1216-8. PubMed ID: 17425927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [What do vasoactive peptides tell about the heart?].
    Uusimaa P
    Duodecim; 1998; 22(114):2281, 2283-4. PubMed ID: 11757087
    [No Abstract]   [Full Text] [Related]  

  • 15. Natriuretic peptides for guiding heart failure therapy.
    Rehman SU; Januzzi JL
    Compr Ther; 2008; 34(1):32-40. PubMed ID: 18681110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natriuretic peptides and other biomarkers in chronic heart failure: from BNP, NT-proBNP, and MR-proANP to routine biochemical markers.
    Lainscak M; von Haehling S; Anker SD
    Int J Cardiol; 2009 Mar; 132(3):303-11. PubMed ID: 19144431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preamble: National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for utilization of biomarkers in acute coronary syndromes and heart failure.
    Christenson RH
    Clin Biochem; 2008 Mar; 41(4-5):208-9. PubMed ID: 17765213
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluating the evidence for assessing BNP and NT-proBNP levels.
    Busse JW; Bassler D; Guyatt GH
    Clin Biochem; 2008 Mar; 41(4-5):227-30. PubMed ID: 17949704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure.
    Kuhn M; Voss M; Mitko D; Stypmann J; Schmid C; Kawaguchi N; Grabellus F; Baba HA
    Cardiovasc Res; 2004 Nov; 64(2):308-14. PubMed ID: 15485690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biomarkers of heart failure.
    Apple FS; Wu AH; Jaffe AS; Panteghini M; Christenson RH; ;
    Clin Biochem; 2008 Mar; 41(4-5):222-6. PubMed ID: 18035345
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.